Journal of translational medicine
Journal
Overview
publication venue for
-
Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation..
22.
2024
-
Cancer cell-selective induction of mitochondrial stress and immunogenic cell death by PT-112 in human prostate cell lines..
22.
2024
-
Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations..
22.
2024
-
Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer..
21.
2023
-
The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022..
21.
2023
-
An integrated multi-omic approach demonstrates distinct molecular signatures between human obesity with and without metabolic complications: a case-control study..
21.
2023
-
The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature..
21.
2023
-
Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors..
21.
2023
-
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer..
21.
2023
-
M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma..
21.
2023
-
DNA methylation predicts the outcome of COVID-19 patients with acute respiratory distress syndrome..
20.
2022
-
Assessing the genetic burden of familial hypercholesterolemia in a large middle eastern biobank..
20.
2022
-
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021..
20.
2022
-
Discovery of new therapeutic targets in ovarian cancer through identifying significantly non-mutated genes..
20.
2022
-
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021..
20.
2022
-
Analysis of lncRNA-miRNA-mRNA expression pattern in heart tissue after total body radiation in a mouse model..
19.
2021
-
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy)..
19.
2021
-
Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients..
19.
2021
-
Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors..
18.
2020
-
Metabolic profiling of pre-gestational and gestational diabetes mellitus identifies novel predictors of pre-term delivery..
18.
2020
-
Prevalence of antibodies against a cyclic peptide mimicking the FG loop of the human papillomavirus type 16 capsid among Tunisian women..
18.
2020
-
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated..
18.
2020
-
The Great Debate at "Melanoma Bridge", Naples, December 7th, 2019..
18.
2020
-
Metabolic signature of obesity-associated insulin resistance and type 2 diabetes..
17.
2019
-
In vivo model of human post-traumatic heterotopic ossification demonstrates early fibroproliferative signature..
17.
2019
-
Akt-activated endothelium promotes ovarian cancer proliferation through notch activation..
17.
2019
-
Screening and identification of potential novel biomarker for diagnosis of complicated Plasmodium vivax malaria..
16.
2018
-
Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank Project..
16.
2018
-
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors..
16.
2018
-
Prostate cancer small non-coding RNA transcriptome in Arabs..
15.
2017
-
Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics..
15.
2017
-
E-cadherin genetic variants predict survival outcome in breast cancer patients..
14.
2016
-
Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts..
14.
2016
-
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015..
14.
2016
-
Measurement of 1,5-anhydroglucitol in blood and saliva: from non-targeted metabolomics to biochemical assay..
14.
2016
-
Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis..
13.
2015
-
Metabolic signatures differentiate ovarian from colon cancer cell lines..
13.
2015
-
The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts..
13.
2015
-
Comprehensive molecular characterization of human adipocytes reveals a transient brown phenotype..
13.
2015
-
Obesity susceptibility loci in Qataris, a highly consanguineous Arabian population..
13.
2015
-
A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancer..
13.
2015
-
Role of SLMAP genetic variants in susceptibility of diabetes and diabetic retinopathy in Qatari population..
13.
2015
-
Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche..
13.
2015
-
Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)..
13.
2015
-
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy..
12.
2014
-
Molecular epidemiology and genotype distribution of Human Papillomavirus (HPV) among Arab women in the State of Qatar..
12.
2014
-
Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder..
12.
2014
-
Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasis..
12.
2014
-
Metabolomics of Ramadan fasting: an opportunity for the controlled study of physiological responses to food intake..
12.
2014
-
Cohort profile: Greifswald approach to individualized medicine (GANI_MED)..
12.
2014
-
Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile..
12.
2014
-
Rat model of veno-arterial extracorporeal membrane oxygenation..
12.
2014
-
Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study..
12.
2014
-
Melanoma risk loci as determinants of melanoma recurrence and survival..
11.
2013
-
Modulation of cardiometabolic pathways in skin and serum from patients with psoriasis..
11.
2013
-
Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy..
11.
2013
-
Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians..
11.
2013
-
Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice..
11.
2013
-
Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance..
11.
2013
-
Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model..
11.
2013
-
Serum microRNAs as biomarkers for recurrence in melanoma..
10.
2012
-
Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis..
10.
2012
-
Engaging basic scientists in translational research: identifying opportunities, overcoming obstacles..
10.
2012
-
The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design..
9.
2011
-
Biobanking after robotic-assisted radical prostatectomy: a quality assessment of providing prostate tissue for RNA studies..
9.
2011
-
Copy number and gene expression differences between African American and Caucasian American prostate cancer..
8.
2010
-
Increased shedding of HU177 correlates with worse prognosis in primary melanoma..
8.
2010
-
Optical imaging of the peri-tumoral inflammatory response in breast cancer..
7.
2009
-
Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life..
7.
2009
-
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells..
6.
2008
-
Detection of postoperative granulation tissue with an ICG-enhanced integrated OI-/X-ray System..
6.
2008
-
Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients..
6.
2008
-
The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo..
5.
2007
-
Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins..
5.
2007
-
Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis..
5.
2007
-
Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians..
5.
2007
-
CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia..
5.
2007
-
Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma..
5.
2007
-
Laser-assisted blastocyst dissection and subsequent cultivation of embryonic stem cells in a serum/cell free culture system: applications and preliminary results in a murine model..
4.
2006
-
Clinical significance of BRAF mutations in metastatic melanoma..
2.
2004
-
Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines..
2.
2004
-
Nicotinamide drives T cell activation in the mammary tumor microenvironment.
2022
-
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy).
2019
-
Immune radiobiology..
19.
2021
-
Personalized medicine: a patient-centered paradigm..
9.
2011
-
Precision medicine in the era of artificial intelligence: implications in chronic disease management.
2020
-
Angiocrine endothelium: from physiology to cancer.
2020
-
Genetic testing and genomic analysis: a debate on ethical, social and legal issues in the Arab world with a focus on Qatar.
2015
-
Cancer classification using the Immunoscore: a worldwide task force.
2012
-
Considerations in the development of circulating tumor cell technology for clinical use.
2012
-
An immunologic portrait of cancer.
2011
-
Conserved genes regulating human sex differentiation, gametogenesis and fertilization.
2024
-
Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era.
2021
-
Role of mesenchymal cells in the natural history of ovarian cancer: a review.
2014
-
Medical education and research environment in Qatar: a new epoch for translational research in the Middle East.
2011
Identity
ISO Abbreviation
Linking ISSN
Electronic International Standard Serial Number (EISSN)